Skip to main content
Complete Olympic Games coverage at your fingertips
Your inside track on the Olympic Games
Enjoy unlimited digital access
$1.99
per week for 24 weeks
Complete Olympic Games coverage at your fingertips
Your inside track onthe Olympics Games
$1.99
per week
for 24 weeks
// //

Kingsway Financial Services Inc. says it has agreed to sell its shares of Jevco Insurance Co. to Westaim Corp. of Calgary.

The total estimated dollar-value of the transaction wasn't disclosed in Monday's announcement but Kingsway said it would receive 94.5 per cent of Jevco's book value as of Dec. 31, subject to adjustments.

In addition, prior to closing the sale, Kingsway would receive a $40-million dividend from Jevco.

Story continues below advertisement

The deal requires approval from the Minister of Finance and Westaim shareholders.

Westaim's primary asset currently is its 75 per cent interest in Nucryst Pharmaceuticals Corp. (TSX:NCS).

Based in Mississauga, Kingsway operates through a number of subsidiaries in the United States and Canada. Jevco is a federally regulated property and casualty insurance company

Kingsway said it has conditional agreements to repurchase about $47-million (U.S.) of its outstanding debt if the Jevco deal is completed successfully.



Report an error
Tickers mentioned in this story
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies